S
36.63
1.79 (5.14%)
| 前收盘价格 | 34.84 |
| 收盘价格 | 35.02 |
| 成交量 | 1,320,217 |
| 平均成交量 (3个月) | 710,798 |
| 市值 | 2,842,199,808 |
| 价格/销量 (P/S) | 650.22 |
| 股市价格/股市净资产 (P/B) | 5.70 |
| 52周波幅 | |
| 利润日期 | 19 Feb 2026 |
| 稀释每股收益 (EPS TTM) | -3.06 |
| 总债务/股东权益 (D/E MRQ) | 0.06% |
| 流动比率 (MRQ) | 8.06 |
| 营业现金流 (OCF TTM) | -169.86 M |
| 杠杆自由现金流 (LFCF TTM) | -68.57 M |
| 资产报酬率 (ROA TTM) | -25.34% |
| 股东权益报酬率 (ROE TTM) | -65.82% |
市场趋势
| 短期 | 中期 | ||
| 行业 | Biotechnology (US) | 看涨 | 混合的 |
| Biotechnology (全球的) | 看涨 | 混合的 | |
| 股票 | Spyre Therapeutics, Inc. | 看跌 | 看跌 |
AIStockmoo 评分
0.3
| 分析师共识 | 2.0 |
| 内部交易活动 | -2.5 |
| 价格波动 | -4.5 |
| 技术平均移动指标 | 2.5 |
| 技术振荡指标 | 4.0 |
| 平均 | 0.30 |
|
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease. |
|
| 部门 | Healthcare |
| 行业 | Biotechnology |
| 投资方式 | Small Value |
| 内部持股比例 | 8.71% |
| 机构持股比例 | 106.07% |
| 52周波幅 | ||
| 目标价格波幅 | ||
| 高 | 70.00 (BTIG, 91.10%) | 购买 |
| 中 | 58.50 (59.71%) | |
| 低 | 50.00 (Wells Fargo, 36.50%) | 购买 |
| 平均值 | 59.25 (61.75%) | |
| 总计 | 4 购买 | |
| 平均价格@调整类型 | 38.24 | |
| 公司 | 日期 | 目标价格 | 调整类型 | 价格@调整类型 |
|---|---|---|---|---|
| BTIG | 20 Feb 2026 | 70.00 (91.10%) | 购买 | 43.21 |
| 16 Jan 2026 | 70.00 (91.10%) | 购买 | 33.24 | |
| Wells Fargo | 20 Feb 2026 | 50.00 (36.50%) | 购买 | 43.21 |
| Mizuho | 18 Dec 2025 | 53.00 (44.69%) | 购买 | 33.47 |
| Citigroup | 17 Dec 2025 | 64.00 (74.72%) | 购买 | 33.06 |
| 名称 | 平均购买 ($) | 平均卖出 ($) | 总净额 | 总净值 ($) |
|---|---|---|---|---|
| BURROWS SCOTT L | - | 40.07 | -2,500 | -100,175 |
| TURTLE CAMERON | - | 42.49 | -15,000 | -637,350 |
| 累积净数量 | -17,500 | |||
| 累积净值 ($) | -737,525 | |||
| 累积平均购买 ($) | - | |||
| 累积平均卖出 ($) | 41.28 | |||
| 名称 | 持有人 | 日期 | 类型 | 数量 | 价格 | 价值 ($) |
|---|---|---|---|---|---|---|
| BURROWS SCOTT L | 职员 | 03 Mar 2026 | 自动卖出 (-) | 2,500 | 40.07 | 100,175 |
| BURROWS SCOTT L | 职员 | 03 Mar 2026 | 执行期权 | 2,500 | - | - |
| TURTLE CAMERON | 职员 | 02 Mar 2026 | 自动卖出 (-) | 15,000 | 42.49 | 637,350 |
| 日期 | 类型 | 细节 |
|---|---|---|
| 06 Feb 2026 | 公告 | Spyre Therapeutics Announces Grants of Inducement Awards |
| 23 Jan 2026 | 公告 | Spyre Therapeutics Announces Grants of Inducement Awards |
| 12 Jan 2026 | 公告 | Spyre Therapeutics Poised for Transformational 2026 With Six Expected Proof-of-Concept Readouts Beginning in Q2 |
| 08 Jan 2026 | 公告 | Spyre Therapeutics Announces Grants of Inducement Awards |
支撑、阻力和趋势线水平是由人工智能（AI）模型生成的，请谨慎解读。
投资组合